Understanding how childhood obesity affects the risk of a serious inflammatory condition in children after COVID-19.

Mechanisms of childhood obesity underlying the susceptibility to multisystem inflammatory syndrome in children (MIS-C)

NIH-funded research Boston Children's Hospital · NIH-10641777

This study is looking at how being overweight or obese might make kids more likely to get a serious condition called MIS-C after a COVID-19 infection, and it aims to find out why this happens so we can better protect and treat those kids.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10641777 on NIH RePORTER

What this research studies

This research investigates the link between childhood obesity and the risk of developing Multisystem Inflammatory Syndrome in Children (MIS-C), a severe complication following SARS-CoV-2 infection. The study aims to uncover the mechanisms by which obesity may increase susceptibility to MIS-C, focusing on immune responses and genetic factors. By analyzing immune cell activation and inflammatory signaling in overweight and obese children, the research seeks to identify specific risk factors that contribute to more severe disease outcomes. The findings could help inform prevention strategies and treatment options for affected children.

Who could benefit from this research

Good fit: Ideal candidates for this research are children who are overweight or obese and have experienced COVID-19 or its aftermath.

Not a fit: Children who are of normal weight and have not been affected by COVID-19 may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and management of MIS-C in children, particularly those with obesity.

How similar studies have performed: Previous research has indicated a connection between obesity and severe inflammatory responses in children, suggesting that this study builds on established findings.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseasesautoimmune disorderautoimmunity diseaseBlood Coagulation DisordersCoagulation Disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.